NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,425.20 -0.70 (-0.03%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,812.00 +217.54 (+0.40%)
VRTX Oct 2024 260.000 put
| Previous close | 1.5500 |
| Open | 1.3500 |
| Bid | 0.0000 |
| Ask | 4.4000 |
| Strike | 260.00 |
| Expiry date | 2024-10-18 |
| Day's range | 1.3500 - 1.5500 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
ZacksVertex (VRTX) Outperforms Industry on Rapid Pipeline Progress
While CF remains the main area of focus, Vertex (VRTX) has seen rapid success in its non-CF pipeline candidates' development in the past year.
ZacksAre You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Business WireJennifer Schneider Elected to Vertex Board of Directors
BOSTON, May 15, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director. Dr. Schneider has more than two decades of experience in the health care industry as a physician, scientist and health care executive. She co-founded and serves as Chief Executive Officer of Homeward Health, a company committed to rearchitecting the delivery of health and care for nearly 60 million Ame
